ArticleCell signaling2026

Histamine H1 receptor: A target to treat pancreatic ductal adenocarcinoma (PDAC) by repurposing approved H1-antihistamines?

Paul A Insel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.